Common Contracts

EX-2.1 2 d546764dex21.htm EX-2.1 AGREEMENT AND PLAN OF MERGER BY AND AMONG VALEANT PHARMACEUTICALS INTERNATIONAL, VALEANT PHARMACEUTICALS INTERNATIONAL, INC., STRATOS MERGER CORP. and BAUSCH & LOMB HOLDINGS INCORPORATED Dated as of May 24, 2013 Page...

Merger Agreement • May 5th, 2020 • Delaware

• Contract Type
  Merger Agreement
• Filed
  May 5th, 2020
• Jurisdiction
  Delaware

AGREEMENT AND PLAN OF MERGER (this “Agreement”), dated as of May 24, 2013, by and among Valeant Pharmaceuticals International, a Delaware corporation (“Parent”), Stratos Merger Corp., a Delaware corporation (“Merger Sub”), and Bausch & Lomb Holdings Incorporated, a Delaware corporation (the “Company”), and, with respect to Section 8.22 and the other provisions of Article VIII related thereto, Valeant Pharmaceuticals International, Inc., a Canadian corporation (“Parent Holdco”).

AGREEMENT AND PLAN OF MERGER BY AND AMONG VALEANT PHARMACEUTICALS INTERNATIONAL, VALEANT PHARMACEUTICALS INTERNATIONAL, INC., STRATOS MERGER CORP. and BAUSCH & LOMB HOLDINGS INCORPORATED Dated as of May 24, 2013

Merger Agreement • May 31st, 2013 • Valeant Pharmaceuticals International, Inc. • Pharmaceutical preparations • Delaware

• Contract Type
  Merger Agreement
• Filed
  May 31st, 2013
• Company
  Valeant Pharmaceuticals International, Inc.
• Industry
  Pharmaceutical preparations
• Jurisdiction
  Delaware

AGREEMENT AND PLAN OF MERGER (this “Agreement”), dated as of May 24, 2013, by and among Valeant Pharmaceuticals International, a Delaware corporation (“Parent”), Stratos Merger Corp., a Delaware corporation (“Merger Sub”), and Bausch & Lomb Holdings Incorporated, a Delaware corporation (the “Company”), and, with respect to Section 8.22 and the other provisions of Article VIII related thereto, Valeant Pharmaceuticals International, Inc., a Canadian corporation (“Parent Holdco”).